SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease
In Parkinson's disease (PD), cognitive functions mediated by brain regions innervated by ventral tegmental area (VTA) worsen with dopamine replacement therapy, whereas processes relying on regions innervated by the substantia nigra pars compacta (SNc) improve. The SLC6A3 gene encodes the dopami...
Main Authors: | Brian D. Robertson, Abdullah S. Al Jaja, Alex A. MacDonald, Nole M. Hiebert, Ruzbeh Tamjeedi, Ken N. Seergobin, Ute I. Schwarz, Richard B. Kim, Penny A. MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2018.00693/full |
Similar Items
-
Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson’s disease
by: Andrew eVo, et al.
Published: (2014-10-01) -
Striatum-Mediated Deficits in Stimulus-Response Learning and Decision-Making in OCD
by: Nole M. Hiebert, et al.
Published: (2020-02-01) -
Differential effects of Parkinson's disease and dopamine replacement on memory encoding and retrieval.
by: Alex A MacDonald, et al.
Published: (2013-01-01) -
Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
by: Xue Q. Yang, et al.
Published: (2018-01-01) -
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
by: Xue Qing Yang, et al.
Published: (2016-10-01)